(Stroke. 2001;32:2939.)
© 2001 American Heart Association, Inc.
Research Report |
From the Department of Neurology (J.F.M., T.G.B.) and Section of Pharmacology (J.H.), Mayo Clinic, Jacksonville, Fla, and the Department of Neurology (R.D.B.) and Section of Biostatistics (E.J.A., P.C.OB.), Mayo Clinic, Rochester, Minn.
Reprint requests to James F. Meschia, MD, Department of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224.
Abstract
Background and Purpose We sought to determine pedigree availability for a concordant sibling pair study of genetic risk factors in ischemic stroke.
Methods Probands with confirmed ischemic stroke were prospectively enrolled. Family histories were obtained by systematic interview. A study neurologist prospectively assigned stroke subtype.
Results Of 310 probands (median age, 75 years; range, 26 to 97 years; 48% women), 75% had at least 1 living sibling; 10%, at least 1 concordant living sibling; 2%, at least 1 concordant sibling living in the same city; and 7%, at least 1 concordant living and 1 discordant living sibling. Likelihood of having a concordant sibling increased significantly with proband age, even after adjustment for sibship size (P=0.002). Positive family history of stroke was not related to either proband stroke subtype or risk factor profile.
Conclusions Approximately 10 probands were screened to find 1 potentially concordant living sibling. A concordant sibling pair study should be multicentered and enable enrollment of siblings from diverse geographic areas.
Key Words: cerebral infarction feasibility studies pedigree research risk factors, genetic stroke classification stroke, ischemic
While studies of genes related to atherosclerosis and thrombosis may help to unravel the genetics of stroke risk, linkage studies in siblings might discover chromosomal regions of interest in genes that are not obvious candidates. The sibling pair approach appears promising,1 but because ischemic stroke typically affects the elderly and is often fatal, this method presents logistic challenges. To test the feasibility of a sibling pair study, we established a prospective registry of patients with recent ischemic stroke.
Subjects and Methods
Patients with recent ischemic stroke treated in 2 tertiary referral institutions were eligible if they presented within 180 days after onset of symptoms. Stroke was defined by World Health Organization criteria,2 and ischemic stroke was confirmed with CT or MRI of the head done within 7 days after onset of symptoms.
Patients with the following conditions were excluded: iatrogenic stroke (onset within 48 hours after an invasive cerebrovascular or cardiovascular procedure), stroke due to vasospasm (onset within 60 days after nontraumatic subarachnoid hemorrhage), cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Fabry disease, homocystinuria, mitochondrial encephalopathy with lactic acidosis and strokelike episodes, sickle cell anemia, mechanical heart valve, and biopsy-proven central nervous system vasculitis. We excluded probands when genetic causes were detected because their enrollment might confound future genome scans for novel risk factors. For each proband, a study neurologist confirmed the diagnosis of ischemic stroke and assigned a Trial of Org 10172 in Acute Stroke Treatment (TOAST) subtype3 using available clinical, cardiac, laboratory, and radiographic data.
Proband medical histories were obtained by systematic interview and record review. Family and spouse histories were obtained by systematic interview of the proband or surrogate. Parental histories were taken only for biological parents; sibling histories were taken only for full siblings (half siblings would not be enrolled in a genome screen). Because intracerebral hemorrhage and cerebral infarction are difficult to differentiate by history alone, both were included. Probands had opportunity to contact relatives or review personal records. Siblings were defined as concordant if a history of stroke was known and discordant if no history of stroke was known.
The relationship of family history characteristics to ischemic stroke subtype was tested with
2 and pairwise comparisons. Logistic regression with and without adjustment for sibship size was used to test the relationship of proband characteristics to family history. Exact 95% CIs were calculated for frequency data.
Mayo Foundation Institutional Review Board approved the study.
Results
Between January 1999 and August 2000, 310 probands were enrolled (162 men, 148 women; 306 white, 4 nonwhite). Median age was 75 years (mean, 72±12 years; range, 26 to 97 years). Every effort was made to screen every stroke patient seen in the study time interval. Two patients declined to answer our survey. Table 1 shows baseline characteristics. The number of probands with siblings and parents concordant and discordant for stroke is shown in Table 2. One sibling was a fraternal twin and 3 were identical twins of a proband.
|
|
The 310 probands had a total of 954 siblings: 195 siblings (20%) were concordant for stroke; 109 (11%) were concordant and living. Of concordant living siblings, 45 (41%) were aged within±5 years of their respective proband; 68 (62%) were aged within±10 years. Of the 105 probands aged
70 years, 15 (14%) had at least 1 concordant sibling; 11 (10%) had at least 1 living concordant sibling. Of 205 probands aged >70 years, 42 (20%) had at least 1 concordant sibling; 19 (9%) had at least 1 living concordant sibling. The likelihood of having a concordant sibling increased significantly with proband age (P=0.0015), even after adjustment for sibship size (P=0.002), but there was no relationship between proband age and likelihood of having a living concordant sibling or a discordant sibling. Likelihood of having a living discordant sibling decreased significantly with proband age (P<0.001), even after adjustment for sibship size (P<0.001). Men and women were equally likely to have a concordant sibling and were equally likely to have a living concordant sibling. Proband status for diabetes, hypertension, and smoking did not influence the likelihood of having a concordant sibling or a living concordant sibling or the probands stroke subtype.
The percentage of probands who had at least 1 sibling with stroke was 16% (95% CI, 8% to 26%) for probands with large-artery, 25% (95% CI, 15% to 39%) for cardioembolic, 18% (95% CI, 10% to 29%) for small-vessel, 13% (95% CI, 0.3% to 53%) for other, and 17% (95% CI, 11% to 26%) for unknown subtype (P=0.647). The percentage of probands who had a sibling or parent with stroke was 42% (95% CI, 30% to 53%) for probands with large-artery, 45% (95% CI, 32% to 59%) for cardioembolic, 48% (95% CI, 35% to 60%) for small-vessel, 38% (95% CI, 8% to 76%) for other, and 51% (95% CI, 41% to 61%) for unknown subtype.
Discussion
Approximately 10 probands must be screened to find 1 potentially concordant sibling pair. Screening of an even larger number would be required to enroll a verified concordant sibling pair. Not every sibling with a history of stroke would have a well-documented ischemic stroke, and some would refuse participation.
Because most siblings did not live in the probands city, a sibling pair study in stroke should be designed so that sibling phenotype can be verified and DNA collected even if the sibling does not live near a center enrolling probands. A multicenter sibling pair collection strategy would be feasible and efficient for this purpose. A pilot test of a multicenter strategy for recruiting pedigrees with a centralized phenotype verification process was recently completed.4
Larger studies should test whether positive family history for stroke relates to proband TOAST subtype. Our study suggests that the magnitude of inherited risk might not vary by ischemic stroke subtype. However, it may be relevant to recognize heterogeneity of phenotype because the molecular basis for inherited risk may vary. Genetic risk may act through common intermediate phenotypes such as diabetes and hypertension, but we found no relationship of risk factors to familial clustering of stroke.
Acknowledgments
This study was supported in part by the National Institute for Neurological Disorders and Stroke (NS39987) and the Mayo Foundation for Medical Education and Research. We thank Linda J. Hall and Colleen Albers for excellent coordinator services and Missy Clingenpeel for assistance in preparing this manuscript.
Received February 2, 2001; revision received September 13, 2001; accepted September 14, 2001.
References
1.
Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, Spurlock G, Norton N, Williams H, Williams N, Lovestone S, Perez-Tur J, Hutton M, Chartier-Harlin MC, Shears S, Roehl K, Booth J, Van Voorst W, Ramic D, Williams J, Goate A, Hardy J, Owen MJ. A full genome scan for late onset Alzheimers disease. Hum Mol Genet. 1999; 8: 237245.
2. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976; 54: 541553.[Medline] [Order article via Infotrieve]
3.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EEIII. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 3541.
4. Meschia JF, Brott TG, Hardy J, Brown RD Jr, Dodick DW, Cornwell KB. Genome-wide screen for stroke: pilot testing in the Siblings With Ischemic Stroke Study (SWISS). J Stroke Cerebrovasc Dis. 2000; 9: 276281.
This article has been cited by other articles:
![]() |
S. Debette and S. Seshadri Genetics of Atherothrombotic and Lacunar Stroke Circ Cardiovasc Genet, April 1, 2009; 2(2): 191 - 198. [Full Text] [PDF] |
||||
![]() |
P. G. Wiklund, W. M. Brown, T. G. Brott, B. Stegmayr, R. D. Brown Jr, S. Nilsson-Ardnor, J. A. Hardy, B. M. Kissela, A. Singleton, D. Holmberg, et al. Lack of aggregation of ischemic stroke subtypes within affected sibling pairs Neurology, February 6, 2007; 68(6): 427 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, B. M. Kissela, T. G. Brott, R. D. Brown Jr, B. B. Worrall, J. Beck, and A. N. Skarp The Siblings With Ischemic Stroke Study (SWISS): A Progress Report. Clin. Med. Res., March 1, 2006; 4(1): 12 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jood, C. Ladenvall, A. Rosengren, C. Blomstrand, and C. Jern Family History in Ischemic Stroke Before 70 Years of Age: The Sahlgrenska Academy Study on Ischemic Stroke Stroke, July 1, 2005; 36(7): 1383 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.G.R. Schulz, E. Flossmann, and P.M. Rothwell Heritability of Ischemic Stroke in Relation to Age, Vascular Risk Factors, and Subtypes of Incident Stroke in Population-Based Studies Stroke, April 1, 2004; 35(4): 819 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Flossmann, U. G.R. Schulz, and P. M. Rothwell Systematic Review of Methods and Results of Studies of the Genetic Epidemiology of Ischemic Stroke Stroke, January 1, 2004; 35(1): 212 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, E. J. Atkinson, P. C. O'Brien, T. G. Brott, R. D. Brown Jr, and J. Hardy Familial Clustering of Stroke According to Proband Age at Onset of Presenting Ischemic Stroke Stroke, July 1, 2003; 34 (7): e89 - e91. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jerrard-Dunne, G. Cloud, A. Hassan, and H. S. Markus Evaluating the Genetic Component of Ischemic Stroke Subtypes: A Family History Study Stroke, June 1, 2003; 34(6): 1364 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, T. G. Brott, R. D. Brown Jr., the Siblings with Ischemic Stroke Study Investigat, J. K.T. Ngeh, and V. K.L. Toh Genetics of Stroke N. Engl. J. Med., April 3, 2003; 348(14): 1407 - 1407. [Full Text] [PDF] |
||||
![]() |
J. F. Meschia, T. G. Brott, R. D. Brown Jr., B. M. Kissela, and S. S. Rich Planning genetic studies and human stroke: Sample size estimates based on family history data Neurology, October 22, 2002; 59(8): 1292 - 1292. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |